Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Venture Capital News: Breaking Venture Capital News, Comments and Articles. - Page: 4

01:47 EDT 20th April 2014 | BioPortfolio

Venture Capital News - Page: 4RSS

Read the latest Venture Capital News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Venture Capital.

Search or Follow Our Venture Capital - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Venture Capital - Page: 4 News.

Showing "venture capital" News Articles 76 to 100 of 7,000+

Wednesday 16th April 2014

In a New Audio Interview at SmallCapVoice.com, Lisa Nelson, CEO of ML Capital Group, Inc., Discusses the Future Plans for the SuperStar Vapor Pen

AUSTIN, Texas, April 17, 2014 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. announced today that a new audio interview with ML Capital Group, Inc., (OTCQB:MLCG) is now available. The interview can be heard at http://smallcapvoice.com/blog/4-16-14-smallcapvoice-interview-with-ml-capital-group-mlcg Lisa Nelson, President and CEO of ML Capital Group, Inc. called back in to SmallCapVoice.com to discu...

GSV Capital Corp. to Host Fifth Annual ASU + GSV Education Innovation Summit

WOODSIDE, Calif., April 17, 2014 (GLOBE NEWSWIRE) -- GSV Capital Corp., ("GSV"), (Nasdaq:GSVC), will co-host the Fifth Annual ASU + GSV Education Innovation Summit April 21-23 at the Phoenician Resort in Scottsdale, AZ. Now in its fifth year, the 2014 Arizona State University + GSV Education Innovation Summit, known to many as "Davos in the Desert," is a dynamic, three-day convergence of indust...

Four Hidden Australian Life Sciences Growth Stocks Revealed: Scott Power

The Life Sciences Report: You are based in Brisbane, Australia, where your firm, Morgans Financial, is headquartered. All the names on your coverage list have traded on the Australian Securities Exchange (ASX). How would you compare investing in Australian biotech or medtech stocks to investing in those same types of stocks in the U.S. or Europe? SP: The Australian market is well established, and...

North American Partners in Anesthesia Partners With East Side Endoscopy as Exclusive Provider of Anesthesia Services

MELVILLE, NY--(Marketwired - April 17, 2014) - North American Partners in Anesthesia (NAPA), the largest single specialty anesthesia and perioperative management company in the United States, and East Side Endoscopy (ESNY) located in Manhattan, NY today announced their partnership. NAPA will serve as the exclusive provider of anesthesiology services and will align with the Surgery Center to provid...

Sunny J. Barkats Will Be a Panelist on Regulation A at the Growth Capital Expo in Las Vegas

NEW YORK, April 17, 2014 (GLOBE NEWSWIRE) -- JSBarkats, PLLC (www.jsbarkats.com ), announced today the participation of Sunny J. Barkats, Esq., at the Growth Capital Expo to be held at The Caesars Palace in Las Vegas, Nevada, from April 29 to May 1, 2014. For more info see: http://www.growthcapitalexpo.com/ "This panel will bring some light on how capital formation could be achieved through Reg...

Capital Bank Financial Corp. Reports First Quarter Net Income of $11.4 Million or $0.22 Per Diluted Share and Core Net Income of $12.4 Million or $0.24 Per Diluted Share

Net income increase of 98% over the prior year first quarter; Yield on $252.5 million of new loans up sequentially 50 basis points to 4.00%; Legacy credit expenses down 14% and 30% over the prior year fourth and first quarter, respectively; ROA and core ROA increased 38 and 21 basis points to 0.70% and 0.76%, respectively, over the prior year first quarter; and Tangible Book...

Nexvet raises $33.6m in financing round

Melbourne-based Nexvet Biopharma has raised US$31.5 million ($33.6 million) via a Series B financing round, and plans to use the proceeds to help fund its clinical programs.The funding round was led by US-based institutional investors Farallon Capital Management, Adage Capital Partners and Foresite Capital, and Tavistock Life Sciences subsidiary fund Boxer Capital.Nexvet’s lead programs cons...

Queensland Government to inject $1m into MRCF

The Queensland Government plans to inject $1 million into the Medical Research Commercialisation Fund (MRCF), a VC fund dedicated to supporting the commercialisation of early-stage medical research.The MRCF also receives funding from the federal government and the governments of Victoria, New South Wales and Western Australia.So far the MRCF has invested in 12 companies, including two medical tech...

Heart Metabolics secures $20 million in series A

Heart Metabolics Ltd. (Dublin, Ireland) raised an undisclosed amount in the first tranche of a planned $20 million series A round from venBio; Seroba Kernal Life Sciences; Brandon Capital Partners; and AshHill. Heart Metabolics is repurposing the gen...

Fertility play Nora raises $18 million in series B

Nora Therapeutics Inc. (Palo Alto, Calif.) raised $18 million in a series B round led by new investor Novo A/S. Existing investors Burrill; Prospect Venture Partners; Rho Ventures; and Vivo Capital also participated. Nora's NT100 is in the Phase II T...

Ampio subsidiary Vyrix files for IPO

The Vyrix Pharmaceutical Inc. subsidiary of Ampio Pharmaceuticals Inc. (NYSE-M:AMPE) filed to raise up to $28.8 million in an IPO on NYSE MKT. Aegis Capital and Fordham are underwriters. Ampio carved off its sexual dysfunction business into Vyrix in...

Fitch Affirms Upland Hills Health (PA) Revs at 'BBB+'; Outlook Stable

Fitch Ratings has affirmed the 'BBB+' rating on the following Wisconsin Health and Educational Facilities Authority Bonds issued on behalf of Upland Hills Health (UHH): --$7.2 million revenue refunding bonds, series 2006A; --$10.5 million revenue bonds, series 2006B; --$9.7 million revenue bonds, series 2006C*. *T...

CNS biotech Newron raises CHF18.6mm in private placement

Existing institutional investors and new backers from Europe and the US joined for a CHF18.6mm ($20.9mm) financing for Newron Pharmaceuticals SPA (focused on Parkinson’s and other neurological diseases, including rare disorders), which sold 1.2mm s...

Debt offering brings up to $45mm to NanoString Technologies

NanoString Technologies Inc. (single-molecule detection and counting tools; molecular diagnostics for cancer) netted $19mm ($20mm gross) up front in a debt offering to Capital Royalty and affiliates (Capital Royalty Partners II, Capital Royalty Partn...

Unmanaged Asthma Takes Its Toll on Low-Income DC Children and Families

Two reports released today by Children's National Health System, the Urban Institute, and DC Appleseed Center for Law and Justice discuss need to undertake a powerful, coordinated response to overcome challenges faced by growing numbers of low-income children in Washington, DC suffering with unmanaged asthma. Washington, DC (PRWEB) April 16, 2014 Healthcare providers, schools, government offi...

Welichem Responds to filing of Take-over Bid Circular

BURNABY, BC, April 16, 2014 /CNW/ - Welichem Biotech Inc. (the "Company") (TSX-V: WBI) has become aware, through the filing on SEDAR on April 15, 2014 of a take-over bid circular dated April 11, 2014, that LJ Resources Co., Ltd. ("LJ"), is making an unsolicited formal offer to purchase all of the outstanding Common shares of the Company at a price of $0.15 per Common share (the "Offer").  T...

St. Jude Medical's CEO Discusses Q1 2014 Results - Earnings Call Transcript

St. Jude Medical, Inc. (STJ) Q1 2014 Earnings Conference Call April 16, 2014 8:00 AM ET Executives Daniel J. Starks – Chairman, President and Chief Executive Officer Donald J. Zurbay – Vice President-Finance and Chief Financial Officer Eric S. Fain – Group President Analysts Robert A. Hopkins – Bank of America Merrill Lynch Mike J. Weinstein – JPMorgan Securities LLC Larry B...

Epirus raises $36 million, to reverse-merge

Biosimilar company Epirus Biopharmaceuticals Inc. (Boston, Mass.) raised $36 million in a series B round and said it will reverse-merge with Zalicus Inc. (NASDAQ:ZLCS) in an all-stock deal. The combined, publicly traded company will retain Epirus' na...

AMD company Iconic closes $20 million round

Iconic Therapeutics Inc. (Atlanta, Ga.) closed a $20 million series B round from new investors MPM Capital; Lundbeckfond Ventures; and H.I.G. BioVentures. Iconic is planning a Phase II trial of hI-con1 to treat wet age-related macular degeneration (A...

Microlin Bio sets IPO range

Microlin Bio Inc. (New York, N.Y.) amended its IPO on NASDAQ and now plans to sell 2.7 million shares at $10-$12. At the $11 midpoint, the company would raise $30 million and be valued at $75.1 million. Brean Capital and Summer Street Research Partne...

Alexza to Report 2014 First Quarter Financial Results on Monday, May 5, 2014

MOUNTAIN VIEW, Calif., April 16, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) will report results for its fiscal quarter ended March 31, 2014 on Monday, May 5, 2014, following the close of the U.S. financial markets.  The Company will also host an investor conference call and live webcast on the same day at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time to provide a compa...

Mentor Capital Flagship Bhang Opens CBD Line at Cannabis Cup

Pricing Efficiencies Spell Trouble for Competition, Price Relief for Consumers Mentor Capital, Inc. (OTC Markets: MNTR) announced that its flagship portfolio company, Bhang Chocolate Company, Inc., will be premiering its newest line of High CBD products at this weekend’s High Times Cannabis Cup in Denver. Starting with Bhang’s 10mg and 25mg gum lin...

If everyone has so many ‘solutions,’ why hasn’t anything in healthcare been solved yet?

Neil Versel Twitter LinkedIn MidAmerica Healthcare Venture Forum, to take place April 22-23 in Chicago, unites active investors with corporate business development executives to facilitate investment opportunities with promising Mid-America...

Healthcare writer Bruce Japsen watching transformation of coverage in private, public sectors

Bruce Japsen Twitter LinkedIn MidAmerica Healthcare Venture Forum, to take place April 22-23 in Chicago, unites active investors with corporate business development executives to facilitate investment opportunities with promising Mid-America...

Vida Cannabis Corp. : Vida Cannabis Corp. Closes US$ 2.5 Million Equity Financing

Toronto, Ontario - April 16, 2014 - Vida Cannabis Corp. ("Vida Cannabis") is pleased to announce it has completed an oversubscribed equity financing, raising US$ 2.5 million via private placement offering of its common stock. Initially, the round was set at US$ 1.5 million. Due to significantly higher interest than anticipated, Vida increased the quantum of financing to US$ 2.5 m...


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement